相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enzyme replacement therapy improves joint motion and outcome of the 12-min walk test in a mucopolysaccharidosis type VI patient previously treated with bone marrow transplantation
Young Bae Sohn et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2012)
Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I mice
Guilherme Baldo et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Severity score system for progressive myelopathy: development and validation of a new clinical scale
R. M. Castilhos et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2012)
Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series
Anke Thuemler et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2012)
A multinational, multidisciplinary consensus for the diagnosis and management of spinal cord compression among patients with mucopolysaccharidosis VI
Guirish A. Solanki et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Neonatal Gene Therapy With a Gamma Retroviral Vector in Mucopolysaccharidosis VI Cats
Katherine P. Ponder et al.
MOLECULAR THERAPY (2012)
Establishment of a novel objective and quantitative method to assess pain-related behavior in monosodium iodoacetate-induced osteoarthritis in rat knee
Hiroyuki Nagase et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2012)
Recent Advances in Treatment Approaches of Mucopolysaccharidosis VI
Roberto Giugliani et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Hyperactive behaviour in the mouse model of mucopolysaccharidosis IIIB in the open field and home cage environments
A. Langford-Smith et al.
GENES BRAIN AND BEHAVIOR (2011)
Efficacy of a Combined Intracerebral and Systemic Gene Delivery Approach for the Treatment of a Severe Lysosomal Storage Disorder
Carmine Spampanato et al.
MOLECULAR THERAPY (2011)
Long-term Amelioration of Feline Mucopolysaccharidosis VI After AAV-mediated Liver Gene Transfer
Gabriella Cotugno et al.
MOLECULAR THERAPY (2011)
Nav1.9 Channel Contributes to Mechanical and Heat Pain Hypersensitivity Induced by Subacute and Chronic Inflammation
Stephane Lolignier et al.
PLOS ONE (2011)
Female Mucopolysaccharidosis IIIA Mice Exhibit Hyperactivity and a Reduced Sense of Danger in the Open Field Test
Alex Langford-Smith et al.
PLOS ONE (2011)
Mental retardation in a patient with Maroteaux-Lamy
S. Vestermark et al.
CLINICAL GENETICS (2010)
Different Serum Enzyme Levels Are Required to Rescue the Various Systemic Features of the Mucopolysaccharidoses
Gabriella Cotugno et al.
HUMAN GENE THERAPY (2010)
Mucopolysaccharidosis VI
Vassili Valayannopoulos et al.
ORPHANET JOURNAL OF RARE DISEASES (2010)
Mucopolysaccharidosis VI: the Italian experience
Maurizio Scarpa et al.
EUROPEAN JOURNAL OF PEDIATRICS (2009)
Gait abnormalities differentially indicate pain or structural joint damage in monoarticular antigen-induced arthritis
Michael K. Boettger et al.
PAIN (2009)
Progression of multiple behavioral deficits with various ages of onset in a murine model of Hurler syndrome
Dao Pan et al.
BRAIN RESEARCH (2008)
Mucopolissacaridose tipo VI (síndrome de Maroteaux-Lamy): avaliação da mobilidade articular e das forças de garra e de pinça
Antonio Cardoso-Santos et al.
Jornal de Pediatria (2008)
Altered Olfactory Epithelial Structure and Function in Feline Models of Mucopolysaccharidoses I and VI
Fritz W. Lischka et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2008)
Clinical characterization of cardiovascular abnormalities associated with feline mucopolysaccharidosis I and VI
M. M. Sleeper et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI:: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase
Paul Harmatz et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Biochemical, pathological, and skeletal improvement of mucopolysaccharidosis VI after gene transfer to liver but not to muscle
Alessandra Tessitore et al.
MOLECULAR THERAPY (2008)
Development of Sensory, Motor and Behavioral Deficits in the Murine Model of Sanfilippo Syndrome Type B
Coy D. Heldermon et al.
PLOS ONE (2007)
Long-term intra-articular administration of recombinant human N-acetylgalactosamine-4-sulfatase in feline mucopolysaccharidosis VI
Dyane Auclair et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Management guidelines for mucopolysaccharidosis VI
Roberto Giugliani et al.
PEDIATRICS (2007)
Topical ketanserin attenuates hyperalgesia and inflammation in arthritis in rats
Yanguo Hong et al.
PAIN (2006)
Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA
Allison C. Crawley et al.
BRAIN RESEARCH (2006)
Intra-articular enzyme administration for joint disease in feline mucopolysaccharidosis VI: Enzyme dose and interval
D Auclair et al.
PEDIATRIC RESEARCH (2006)
Long-term memory for aversive training is impaired in Idua-/- mice, a genetic model of mucopolysaccharidosis type I
GK Reolon et al.
BRAIN RESEARCH (2006)
Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome):: Results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase
P Harmatz et al.
PEDIATRICS (2005)
Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA)
KM Hemsley et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs
RL Mango et al.
MOLECULAR GENETICS AND METABOLISM (2004)
Cardiac and ocular pathologies in a mouse model of mucopolysaccharidosis type VI
OF Strauch et al.
PEDIATRIC RESEARCH (2003)
Spinal and supraspinal changes in opioid mRNA expression are related to the onset of pain behaviors following excitotoxic spinal cord injury
KE Abraham et al.
PAIN (2001)
分享论文
